Haematological cancer: Indolent lymphoma - Why not to sprint at the start of a marathonHumansLymphoma, Mantle-CellAntineoplastic Combined Chemotherapy ProtocolsComment on Lancet. 2013 Apr 6;381(9873):1203-10.doi:10.1038/nrclinonc.2013.53Doucet, Stephane...
Allogeneic hema- topoietic stem cell transplantation for relapsed fol- licular lymphoma: a combined analysis on behalf of the lymphoma working party of the EBMT and the lymphoma committee of the CIBMTR. Cancer. 2018;124(8):1733–42. Thomson KJ, Morris EC, Milligan D, et al. T-...
The OS rate at 10 years was 64% and the cancer-specific survival rate was 71%. Considering the infrequency of early-stage follicular lymphoma and the need for single institutions to include 20 to 30 years’ worth of patients in their studies to provide an adequate cohort, studies that ...
immune suppression of LMP1/CD40-expressing mice was associated with a morphological, immunophenotypic and proliferative shift toward tumor aggressiveness from a preexisting indolent B-cell clone that mimicked the main features of indolent B-cell lymphoma transformation. Thus, as a preclinical model...
Google Share on Facebook Dictionary Medical Encyclopedia Wikipedia Related to indolent:Indolent lymphoma,Indolent ulcer </>embed</> assiduous industrious diligent fainéant lumpish slothful workshy good-for-noth... torpid indolent adj Synonyms for indolent ...
[ZUMA-5; n = 104], the ORR was 92% and investigators reported a 74% CR rate after a 17.5-month median follow-up,” study author Julio C. Chavez, MD, an associate member in the Lymphoma Section of the Department of Malignant Hematology at Moffitt Cancer Center, in Tampa, Florida, ...
Prostate Cancer Indolence vs Aggressiveness Progress in the Treatment of Indolent Non-Hodgkin Lymphoma (NHL) In general usage, however,indolencemeans, “the disposition to avoid trouble; love of ease.” Indolentis also a synonym forlazy.
Optimizing treatment for patients with indolent non-Hodgkin lymphoma (iNHL) has become a challenge as the frontline and recurrent treatment settings continue to evolve, said Brad S. Kahl, MD. "The management of [recurrent] indolent lymphoma is complicated because there are so many variables," said...
2009: Phase Ii study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma Cancer Science 100(10): 1951-1956 Wild, A.; Holasová, J.; Králiková, E. 2018: Use of Fludarabine for the Treatment of Indolent Lymphoma with Chylothorax Klinicka ...
Sonali Smith, MD, discusses T-cell–directed therapies for indolent B-cell lymphoma, focusing on their efficacy, FDA-approved treatments, and treatment challenges, such as managing cytokine release syndrome.